世界のモルキオ症候群治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Morquio Syndrome Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5867 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、モルキオ症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モルキオA、モルキオB）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・モルキオ症候群治療の市場動向 ・企業の競争状況、市場シェア ・モルキオ症候群治療の種類別市場規模と予測2016-2027（モルキオA、モルキオB） ・モルキオ症候群治療の用途別市場規模と予測2016-2027（病院、クリニック、その他） ・モルキオ症候群治療の北米市場規模2016-2027（アメリカ、カナダ） ・モルキオ症候群治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・モルキオ症候群治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・モルキオ症候群治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・モルキオ症候群治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（BioMarin、Genzyme Corporation,、Shire、JCR Pharmaceuticals、Sanofi、Sangamo Therapeutics、Green Cross、Concert Pharmaceuticals、Alexion Pharmaceuticals、Roche、Pfizer、Lupin、Cambrex Corporation、Cipla、Bayer、Daiichi Sankyo） ・結論

Morquio syndrome is a type of mucopolysaccharide metabolic disorder, that is, type Ⅳ in mucopolysaccharide storage disease, also known as hereditary cartilage dystrophy syndrome

Market Analysis and Insights: Global Morquio Syndrome Treatment Market
The global Morquio Syndrome Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Morquio Syndrome Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Morquio Syndrome Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Morquio Syndrome Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Morquio Syndrome Treatment market.

Global Morquio Syndrome Treatment Scope and Market Size
Morquio Syndrome Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Morquio Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Morquio A
Morquio B

Segment by Application
Hospital
Clinic
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BioMarin
Genzyme Corporation,
Shire
JCR Pharmaceuticals
Sanofi
Sangamo Therapeutics
Green Cross
Concert Pharmaceuticals
Alexion Pharmaceuticals
Roche
Pfizer
Lupin
Cambrex Corporation
Cipla
Bayer
Daiichi Sankyo

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Morquio Syndrome Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Morquio A
1.2.3 Morquio B
1.3 Market by Application
1.3.1 Global Morquio Syndrome Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Morquio Syndrome Treatment Market Perspective (2016-2027)
2.2 Morquio Syndrome Treatment Growth Trends by Regions
2.2.1 Morquio Syndrome Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Morquio Syndrome Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Morquio Syndrome Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Morquio Syndrome Treatment Industry Dynamic
2.3.1 Morquio Syndrome Treatment Market Trends
2.3.2 Morquio Syndrome Treatment Market Drivers
2.3.3 Morquio Syndrome Treatment Market Challenges
2.3.4 Morquio Syndrome Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Morquio Syndrome Treatment Players by Revenue
3.1.1 Global Top Morquio Syndrome Treatment Players by Revenue (2016-2021)
3.1.2 Global Morquio Syndrome Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Morquio Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Morquio Syndrome Treatment Revenue
3.4 Global Morquio Syndrome Treatment Market Concentration Ratio
3.4.1 Global Morquio Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Morquio Syndrome Treatment Revenue in 2020
3.5 Morquio Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Morquio Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Morquio Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Morquio Syndrome Treatment Breakdown Data by Type
4.1 Global Morquio Syndrome Treatment Historic Market Size by Type (2016-2021)
4.2 Global Morquio Syndrome Treatment Forecasted Market Size by Type (2022-2027)

5 Morquio Syndrome Treatment Breakdown Data by Application
5.1 Global Morquio Syndrome Treatment Historic Market Size by Application (2016-2021)
5.2 Global Morquio Syndrome Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Morquio Syndrome Treatment Market Size (2016-2027)
6.2 North America Morquio Syndrome Treatment Market Size by Type
6.2.1 North America Morquio Syndrome Treatment Market Size by Type (2016-2021)
6.2.2 North America Morquio Syndrome Treatment Market Size by Type (2022-2027)
6.2.3 North America Morquio Syndrome Treatment Market Size by Type (2016-2027)
6.3 North America Morquio Syndrome Treatment Market Size by Application
6.3.1 North America Morquio Syndrome Treatment Market Size by Application (2016-2021)
6.3.2 North America Morquio Syndrome Treatment Market Size by Application (2022-2027)
6.3.3 North America Morquio Syndrome Treatment Market Size by Application (2016-2027)
6.4 North America Morquio Syndrome Treatment Market Size by Country
6.4.1 North America Morquio Syndrome Treatment Market Size by Country (2016-2021)
6.4.2 North America Morquio Syndrome Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Morquio Syndrome Treatment Market Size (2016-2027)
7.2 Europe Morquio Syndrome Treatment Market Size by Type
7.2.1 Europe Morquio Syndrome Treatment Market Size by Type (2016-2021)
7.2.2 Europe Morquio Syndrome Treatment Market Size by Type (2022-2027)
7.2.3 Europe Morquio Syndrome Treatment Market Size by Type (2016-2027)
7.3 Europe Morquio Syndrome Treatment Market Size by Application
7.3.1 Europe Morquio Syndrome Treatment Market Size by Application (2016-2021)
7.3.2 Europe Morquio Syndrome Treatment Market Size by Application (2022-2027)
7.3.3 Europe Morquio Syndrome Treatment Market Size by Application (2016-2027)
7.4 Europe Morquio Syndrome Treatment Market Size by Country
7.4.1 Europe Morquio Syndrome Treatment Market Size by Country (2016-2021)
7.4.2 Europe Morquio Syndrome Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Morquio Syndrome Treatment Market Size (2016-2027)
8.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Type
8.2.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Application
8.3.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Morquio Syndrome Treatment Market Size by Region
8.4.1 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Morquio Syndrome Treatment Market Size (2016-2027)
9.2 Latin America Morquio Syndrome Treatment Market Size by Type
9.2.1 Latin America Morquio Syndrome Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Morquio Syndrome Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Morquio Syndrome Treatment Market Size by Type (2016-2027)
9.3 Latin America Morquio Syndrome Treatment Market Size by Application
9.3.1 Latin America Morquio Syndrome Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Morquio Syndrome Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Morquio Syndrome Treatment Market Size by Application (2016-2027)
9.4 Latin America Morquio Syndrome Treatment Market Size by Country
9.4.1 Latin America Morquio Syndrome Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Morquio Syndrome Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Morquio Syndrome Treatment Market Size (2016-2027)
10.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Type
10.2.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Application
10.3.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Morquio Syndrome Treatment Market Size by Country
10.4.1 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 BioMarin
11.1.1 BioMarin Company Details
11.1.2 BioMarin Business Overview
11.1.3 BioMarin Morquio Syndrome Treatment Introduction
11.1.4 BioMarin Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.1.5 BioMarin Recent Development
11.2 Genzyme Corporation,
11.2.1 Genzyme Corporation, Company Details
11.2.2 Genzyme Corporation, Business Overview
11.2.3 Genzyme Corporation, Morquio Syndrome Treatment Introduction
11.2.4 Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.2.5 Genzyme Corporation, Recent Development
11.3 Shire
11.3.1 Shire Company Details
11.3.2 Shire Business Overview
11.3.3 Shire Morquio Syndrome Treatment Introduction
11.3.4 Shire Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.3.5 Shire Recent Development
11.4 JCR Pharmaceuticals
11.4.1 JCR Pharmaceuticals Company Details
11.4.2 JCR Pharmaceuticals Business Overview
11.4.3 JCR Pharmaceuticals Morquio Syndrome Treatment Introduction
11.4.4 JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.4.5 JCR Pharmaceuticals Recent Development
11.5 Sanofi
11.5.1 Sanofi Company Details
11.5.2 Sanofi Business Overview
11.5.3 Sanofi Morquio Syndrome Treatment Introduction
11.5.4 Sanofi Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.5.5 Sanofi Recent Development
11.6 Sangamo Therapeutics
11.6.1 Sangamo Therapeutics Company Details
11.6.2 Sangamo Therapeutics Business Overview
11.6.3 Sangamo Therapeutics Morquio Syndrome Treatment Introduction
11.6.4 Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.6.5 Sangamo Therapeutics Recent Development
11.7 Green Cross
11.7.1 Green Cross Company Details
11.7.2 Green Cross Business Overview
11.7.3 Green Cross Morquio Syndrome Treatment Introduction
11.7.4 Green Cross Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.7.5 Green Cross Recent Development
11.8 Concert Pharmaceuticals
11.8.1 Concert Pharmaceuticals Company Details
11.8.2 Concert Pharmaceuticals Business Overview
11.8.3 Concert Pharmaceuticals Morquio Syndrome Treatment Introduction
11.8.4 Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.8.5 Concert Pharmaceuticals Recent Development
11.9 Alexion Pharmaceuticals
11.9.1 Alexion Pharmaceuticals Company Details
11.9.2 Alexion Pharmaceuticals Business Overview
11.9.3 Alexion Pharmaceuticals Morquio Syndrome Treatment Introduction
11.9.4 Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.9.5 Alexion Pharmaceuticals Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Morquio Syndrome Treatment Introduction
11.10.4 Roche Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.10.5 Roche Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Morquio Syndrome Treatment Introduction
11.11.4 Pfizer Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.11.5 Pfizer Recent Development
11.12 Lupin
11.12.1 Lupin Company Details
11.12.2 Lupin Business Overview
11.12.3 Lupin Morquio Syndrome Treatment Introduction
11.12.4 Lupin Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.12.5 Lupin Recent Development
11.13 Cambrex Corporation
11.13.1 Cambrex Corporation Company Details
11.13.2 Cambrex Corporation Business Overview
11.13.3 Cambrex Corporation Morquio Syndrome Treatment Introduction
11.13.4 Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.13.5 Cambrex Corporation Recent Development
11.14 Cipla
11.14.1 Cipla Company Details
11.14.2 Cipla Business Overview
11.14.3 Cipla Morquio Syndrome Treatment Introduction
11.14.4 Cipla Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.14.5 Cipla Recent Development
11.15 Bayer
11.15.1 Bayer Company Details
11.15.2 Bayer Business Overview
11.15.3 Bayer Morquio Syndrome Treatment Introduction
11.15.4 Bayer Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.15.5 Bayer Recent Development
11.16 Daiichi Sankyo
11.16.1 Daiichi Sankyo Company Details
11.16.2 Daiichi Sankyo Business Overview
11.16.3 Daiichi Sankyo Morquio Syndrome Treatment Introduction
11.16.4 Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2016-2021)
11.16.5 Daiichi Sankyo Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Morquio Syndrome Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Morquio A
Table 3. Key Players of Morquio B
Table 4. Global Morquio Syndrome Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Morquio Syndrome Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Morquio Syndrome Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Morquio Syndrome Treatment Market Share by Regions (2016-2021)
Table 8. Global Morquio Syndrome Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Morquio Syndrome Treatment Market Share by Regions (2022-2027)
Table 10. Morquio Syndrome Treatment Market Trends
Table 11. Morquio Syndrome Treatment Market Drivers
Table 12. Morquio Syndrome Treatment Market Challenges
Table 13. Morquio Syndrome Treatment Market Restraints
Table 14. Global Morquio Syndrome Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Morquio Syndrome Treatment Market Share by Players (2016-2021)
Table 16. Global Top Morquio Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morquio Syndrome Treatment as of 2020)
Table 17. Ranking of Global Top Morquio Syndrome Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Morquio Syndrome Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Morquio Syndrome Treatment Product Solution and Service
Table 21. Date of Enter into Morquio Syndrome Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Morquio Syndrome Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Morquio Syndrome Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Morquio Syndrome Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Morquio Syndrome Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Morquio Syndrome Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Morquio Syndrome Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Morquio Syndrome Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Morquio Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Morquio Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Morquio Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Morquio Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Morquio Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Morquio Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Morquio Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Morquio Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Morquio Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Morquio Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Morquio Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Morquio Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Morquio Syndrome Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Morquio Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Morquio Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Morquio Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Morquio Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Morquio Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Morquio Syndrome Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Morquio Syndrome Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Morquio Syndrome Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. BioMarin Company Details
Table 62. BioMarin Business Overview
Table 63. BioMarin Morquio Syndrome Treatment Product
Table 64. BioMarin Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 65. BioMarin Recent Development
Table 66. Genzyme Corporation, Company Details
Table 67. Genzyme Corporation, Business Overview
Table 68. Genzyme Corporation, Morquio Syndrome Treatment Product
Table 69. Genzyme Corporation, Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 70. Genzyme Corporation, Recent Development
Table 71. Shire Company Details
Table 72. Shire Business Overview
Table 73. Shire Morquio Syndrome Treatment Product
Table 74. Shire Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 75. Shire Recent Development
Table 76. JCR Pharmaceuticals Company Details
Table 77. JCR Pharmaceuticals Business Overview
Table 78. JCR Pharmaceuticals Morquio Syndrome Treatment Product
Table 79. JCR Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 80. JCR Pharmaceuticals Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Morquio Syndrome Treatment Product
Table 84. Sanofi Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 85. Sanofi Recent Development
Table 86. Sangamo Therapeutics Company Details
Table 87. Sangamo Therapeutics Business Overview
Table 88. Sangamo Therapeutics Morquio Syndrome Treatment Product
Table 89. Sangamo Therapeutics Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 90. Sangamo Therapeutics Recent Development
Table 91. Green Cross Company Details
Table 92. Green Cross Business Overview
Table 93. Green Cross Morquio Syndrome Treatment Product
Table 94. Green Cross Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 95. Green Cross Recent Development
Table 96. Concert Pharmaceuticals Company Details
Table 97. Concert Pharmaceuticals Business Overview
Table 98. Concert Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 99. Concert Pharmaceuticals Recent Development
Table 100. Alexion Pharmaceuticals Company Details
Table 101. Alexion Pharmaceuticals Business Overview
Table 102. Alexion Pharmaceuticals Morquio Syndrome Treatment Product
Table 103. Alexion Pharmaceuticals Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 104. Alexion Pharmaceuticals Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Morquio Syndrome Treatment Product
Table 108. Roche Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 109. Roche Recent Development
Table 110. Pfizer Company Details
Table 111. Pfizer Business Overview
Table 112. Pfizer Morquio Syndrome Treatment Product
Table 113. Pfizer Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 114. Pfizer Recent Development
Table 115. Lupin Company Details
Table 116. Lupin Business Overview
Table 117. Lupin Morquio Syndrome Treatment Product
Table 118. Lupin Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 119. Lupin Recent Development
Table 120. Cambrex Corporation Company Details
Table 121. Cambrex Corporation Business Overview
Table 122. Cambrex Corporation Morquio Syndrome Treatment Product
Table 123. Cambrex Corporation Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 124. Cambrex Corporation Recent Development
Table 125. Cipla Company Details
Table 126. Cipla Business Overview
Table 127. Cipla Morquio Syndrome Treatment Product
Table 128. Cipla Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 129. Cipla Recent Development
Table 130. Bayer Company Details
Table 131. Bayer Business Overview
Table 132. Bayer Morquio Syndrome Treatment Product
Table 133. Bayer Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 134. Bayer Recent Development
Table 135. Daiichi Sankyo Company Details
Table 136. Daiichi Sankyo Business Overview
Table 137. Daiichi Sankyo Morquio Syndrome Treatment Product
Table 138. Daiichi Sankyo Revenue in Morquio Syndrome Treatment Business (2016-2021) & (US$ Million)
Table 139. Daiichi Sankyo Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Morquio Syndrome Treatment Market Share by Type: 2020 VS 2027
Figure 2. Morquio A Features
Figure 3. Morquio B Features
Figure 4. Global Morquio Syndrome Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Others Case Studies
Figure 8. Morquio Syndrome Treatment Report Years Considered
Figure 9. Global Morquio Syndrome Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Morquio Syndrome Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Morquio Syndrome Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Morquio Syndrome Treatment Market Share by Regions (2022-2027)
Figure 13. Global Morquio Syndrome Treatment Market Share by Players in 2020
Figure 14. Global Top Morquio Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morquio Syndrome Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Morquio Syndrome Treatment Revenue in 2020
Figure 16. Global Morquio Syndrome Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Morquio Syndrome Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Morquio Syndrome Treatment Market Share by Type (2016-2027)
Figure 20. North America Morquio Syndrome Treatment Market Share by Application (2016-2027)
Figure 21. North America Morquio Syndrome Treatment Market Share by Country (2016-2027)
Figure 22. United States Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Morquio Syndrome Treatment Market Share by Type (2016-2027)
Figure 26. Europe Morquio Syndrome Treatment Market Share by Application (2016-2027)
Figure 27. Europe Morquio Syndrome Treatment Market Share by Country (2016-2027)
Figure 28. Germany Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Morquio Syndrome Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Morquio Syndrome Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Morquio Syndrome Treatment Market Share by Region (2016-2027)
Figure 38. China Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Morquio Syndrome Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Morquio Syndrome Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Morquio Syndrome Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Morquio Syndrome Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Morquio Syndrome Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Morquio Syndrome Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Morquio Syndrome Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. BioMarin Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 58. Genzyme Corporation, Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 59. Shire Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 60. JCR Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 61. Sanofi Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 62. Sangamo Therapeutics Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 63. Green Cross Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 64. Concert Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 65. Alexion Pharmaceuticals Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 67. Pfizer Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 68. Lupin Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 69. Cambrex Corporation Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 70. Cipla Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 71. Bayer Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 72. Daiichi Sankyo Revenue Growth Rate in Morquio Syndrome Treatment Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

---